Concepedia

Michael K. Bamat

MK

Statistics

Publications

9

Citations

961

H-Index

9

Active since

1982

Affiliations

Wellstat Biologics (United States)(Current)

Wellstat (United States)

Michael K. Bamat is an author at Wellstat Biologics (United States) specializing in oncolytic virus therapy, oncology, and pharmacology.

Publications per year

1982–2016

9

Publications

9

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

Andrew L. Pecora, Naiyer A. Rizvi, Gary I. Cohen et al. · Journal of Clinical Oncology · 2002 · 389 citations

, , +9

A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization

Scott A. Laurie, John C. Bell, Harold Atkins et al. · Clinical Cancer Research · 2006 · 128 citations · Full text

, , +13

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity

Wen Wee, Muhammad Wasif Saif, Bassel F. El‐Rayes et al. · Cancer · 2016 · 122 citations · Full text

, , +17

An Optimized Clinical Regimen for the Oncolytic Virus PV701

Sebastién J. Hotte, Robert M. Lorence, Hal W. Hirte et al. · Clinical Cancer Research · 2007 · 114 citations · Full text

, , +15

Overview of phase I studies of intravenous administration of PV701, an oncolytic virus.

Major Pp, Sebastién J. Hotte, Scott A. Laurie et al. · PubMed · 2003 · 98 citations

, , +17

1–5 of 9